Top Markets
Coin of the day
F-star Therapeutics, Inc. F-star Therapeutics, Inc.

F-star Therapeutics, Inc.

FSTX
Classificação em ações #21012
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to inventing tetravalent bispecific antibodies for the treatment of cancer, particularly within the field of immuno-oncology. The company's primary investigational product, FS118, is currently in a Phase 2 proof-of-concept trial, evaluating its efficacy in head and neck cancer patients who have acquired resistance to PD-1/PD-L1 therapies. F-star is also advancing FS222, a bispecific antibody designed to simultaneously target the costimulatory CD137 receptor and the inhibitory PD-L1 ligand, through its initial Phase 1 human clinical study. Moreover, two additional drug candidates, FS120 and SB 11285, are undergoing Phase 1 clinical evaluation for patients with advanced malignancies. Founded in 2002, F-star Therapeutics, Inc. has its corporate headquarters situated in Cambridge, United Kingdom.
Preço da ação
$7.12
Última sincronização: 2023-03-08
Valor de mercado
$117.03M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
GB
Negociar F-star Therapeutics, Inc. (FSTX)

Categoria

Histórico de preços das ações de F-star Therapeutics, Inc. (FSTX)
Preço de fecho mais alto: $6.19 em 2023-03-01

Preço de fecho mais baixo: $7.22 em 2021-05-01
Histórico de preços das ações da F-star Therapeutics, Inc. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 14.14%
2022 6.74%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH